← FDA Drug Approvals (Drugs@FDA)

LEVOFLOXACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2015-06-19

Drug application

FDA Application #
ANDA203613
Application type
Abbreviated New Drug Application (Generic)
Brand name
LEVOFLOXACIN
Generic name
Levofloxacin
Active ingredients
LEVOFLOXACIN
Dosage form
TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
JUBILANT GENERICS
First approval
2015-06-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown